Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John S. Wang
Observed name:
John S Wang
Institution:
Duke University
Observed institutions:
Northwestern University,
Duke University,
Duke Medical Center,
University of Virginia Medical Center,
University of Virginia Cancer Center,
University of Virginia
show all 6
ORCID:
0000-0001-5532-2101
Observed ORCID:
0000-0001-5532-2101
OpenAlex ID:
A5062728170
Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia
2022
·
HeeJin Cheon
, Jeffrey C. Xing
, et al.
·
Blood
·
72
PDF
Utilization of exosome-based therapies to augment anti-PD-1/PD-L1 therapies
2025
·
John S. Wang
, Samer Yassin
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
Successful treatment of metastatic pancreatoblastoma in an adult with autologous hematopoietic cell transplant
2020
·
Omar Elghawy
, John S. Wang
, et al.
·
Pancreatology
·
11
Abstract A059: Uncovering Bystander Killing Mechanisms of Trastuzumab Deruxtecan (T-DXd): Effective Extracellular Payload Release via Cathepsin L in HER2-low Breast Cancer.
2024
·
Li-Chung Tsao
, John S. Wang
, et al.
·
Cancer Immunology Research
·
5
Abstract B009: Enhancing Antitumor Immune Responses: Trastuzumab Deruxtecan (T- DXd) Induces Immunogenic Cell Death and Phagocytosis, Synergizing with CD47/SIRPα Checkpoint Blockade
2024
·
Li-Chung Tsao
, John S. Wang
, et al.
·
Cancer Immunology Research
·
5
Gaucher disease type 3c: Expanding the clinical spectrum of an ultra‐rare disease
2024
·
John S. Wang
, Rebecca L. Koch
, et al.
·
JIMD Reports
·
5
PDF
Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome
2022
·
Omar Elghawy
, John S. Wang
, et al.
·
Case Reports in Nephrology and Dialysis
·
5
PDF
Diagnosis and Management of Atypical Chronic Myeloid Leukemia with a t(2;13)(q33;q12) Translocation
2022
·
John S. Wang
, Omar Elghawy
, et al.
·
Case Reports in Hematology
·
3
PDF
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From Surgery
2025
·
John S Wang
, Brandon L Ellsworth
, et al.
·
Clinical Medicine Insights Oncology
·
2
Reporter immunogenicity as a defined rejection antigen: a noninvasive platform for skin transplant immunobiology
2026
·
Sydney Jeffs
, John S. Wang
, et al.
·
Frontiers in Immunology
PDF
Activation of FcγR and classical complement pathways contribute to T-DXd plus pertuzumab therapeutic efficacy
2026
·
Li-Chung Tsao
, John S. Wang
, et al.
·
npj Breast Cancer
PDF
Abstract P5-05-30: Unlocking the Therapeutic Potential of T DXd Enhertu Mechanisms of Action in HER2 Low Cancers and Immunomodulatory Effects
2025
·
Li-Chung Tsao
, John S. Wang
, et al.
·
Clinical Cancer Research
Abstract 2128: Uncovering the multiple therapeutic mechanisms of trastuzumab deruxtecan (T-DXd): effective extracellular payload release and immunomodulatory stimulation
2025
·
Li-Chung Tsao
, John S. Wang
, et al.
·
Cancer Research
Abstract 2377: HER2-ADC efficacy is rooted in its induction of immunogenic cell death with FcGR activation and a systemic bystander effect
2024
·
Li-Chung Tsao
, Xingru Ma
, et al.
·
Cancer Research
Atypical neurological presentation in Gaucher disease type 3C
2024
·
John S. Wang
, Erin Huggins
, et al.
·
Molecular Genetics and Metabolism
Allogeneic Hematopoietic Cell Transplant (HCT) Complications Requiring Transfer to the Intensive Care Unit (ICU) in a Medium Size Program
2021
·
Omar Elghawy
, John S. Wang
, et al.
·
Transplantation and Cellular Therapy
Minimal Change Disease (MCD) Secondary to Chronic Graft Versus Host Disease (GVHD) in Two Adult Patients after Allogeneic (Allo) Hematopoietic Cell Transplant (HCT) for Myelodysplastic Syndrome (MDS)
2021
·
John S. Wang
, Omar Elghawy
, et al.
·
Transplantation and Cellular Therapy
Show more works
View as search
Works count:
17
Citation count:
126
H-index:
5
I10-index:
3
Year
Topic
Type
